FDA Approves Ajovy for Migraine Prevention in Children and Teens
Approval is for children and adolescents aged 6 to 17 years weighing ≥45 kg
Vinay Prasad Returns to FDA After Being Ousted
By I. Edwards HealthDay Reporter
MONDAY, Aug. 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA)’s top vaccine regulator is returning to...
Sustained Clinical Benefit Seen for Pembrolizumab + Axitinib in Advanced Renal Cancer
Sustained benefits seen in overall survival, progression-free survival, objective response rate with combo versus sunitinib
Broader Formulary Coverage Linked to Lower Odds of MS Relapse
Lower odds of relapse seen among Medicare beneficiaries in prescription drug plans, Medicare Advantage Prescription Drug plans
New Weight Loss Pill From Eli Lilly Shows Promise in Early Study
By I. Edwards HealthDay Reporter
FRIDAY, Aug. 8, 2025 (HealthDay News) — A new weight loss pill made by Eli Lilly helped people lose a...
AMA, AAP, IDSA Among Organizations Disinvited From CDC Vaccine Workgroups
Move follows RFK Jr.'s abrupt dismissal of the entire ACIP in June, alleging it was too aligned with manufacturers
Study IDs Barriers to GLP-1 Receptor Agonist Use in Adolescents, Young Adults
A number of young adults eligible for GLP-1 RAs are uninsured
Oseltamivir for Flu Tied to Reduced Risk for Serious Neuropsychiatric Events in Children
Event rates were lower during oseltamivir-treated influenza periods and posttreatment periods vs. untreated influenza
RFK Jr. Cancels $500M in mRNA Vaccine Research Projects
By I. Edwards HealthDay Reporter
THURSDAY, Aug. 7, 2025 (HealthDay News) — U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr....
COVID-19 mRNA Vaccine Targeting Omicron JN.1 Lineage Safe
No significant increases seen in rate of hospital contacts for any of 29 adverse events in 28-day risk period after vaccination
